What they call their work
What they do
-
Biomedical Research and Innovation 1 activity
- Developing and validating novel cancer diagnostic assaysConducted research to develop blood-based tumor marker tests using microRNA 371a-3p and microRNA 372-3p to monitor germ cell tumor disease status in patients with non-elevated traditional markers, and secured New York State Department of Health approval for the MSK MicroRNA Assay (MMA), the first such approval in the United States.
-
-
Cancer Research Funding 1 activity
- Funding cancer research for specific investigators and projectsProvides grants to support individual researchers and targeted cancer research initiatives, including Dr. Darren Feldman's work on germ cell tumors and testicular cancer at Memorial Sloan Kettering Cancer Center, Dr. Alana Nguyen's research on anti-tumor immunity in peritoneal metastatic cancer, and the pancreatic cancer screening awareness campaign led by Drs. Charles M. Noyer and Joshua Raff. All proceeds from annual fundraising are directed to a single selected researcher, organization, or cause each year.
-
-
Charity Golf Tournament Fundraiser 1 activity
- Organizing annual charity golf tournament and associated eventsHosts the 16th Annual Charity Golf Outing, supported by sponsorship tiers offering branding and advertising benefits, and includes a Helicopter Ball Drop event as a launch activity. The event aims to raise $40,000 through the sale of up to 2,000 donated golf balls at $20 each.
-
Who runs it
- Adam Landsman — Board Member
- David Crystal — Board Member
- David Yaches — Board Member
- Michael Beckerman — Board Member
Who they work with
- FOXTROT Partner — Partner organization collaborating with ReMission Foundation on the Helicopter Ball Drop event.
- Memorial Sloan Kettering Cancer Center Partner — Collaborates on the development and clinical application of microRNA assays for germ cell tumors.
- Memorial Sloan Kettering Cancer Center Partner — Collaborates with MSK through funding of Dr. Darren Feldman's research on testicular cancer.
- Memorial Sloan Kettering Cancer Center Partner — Collaborates with MSK to support research for germ cell tumors and testicular cancer led by Dr. Darren Feldman.
- Memorial Sloan Kettering Cancer Center Partner — Collaborates with ReMission Foundation to support research on germ cell tumors and testicular cancer.
- Paramount Country Club Partner — Hosts the annual ReMission Foundation charity golf tournament.
- Weill Cornell Medicine/NewYork-Presbyterian Hospital Partner — Collaborates with ReMission Foundation in supporting research on peritoneal metastatic cancer.
- White Plains Hospital Cancer Center Partner — Collaborates with ReMission Foundation to support the Pancreatic Cancer Screening Awareness Campaign.
- smaller causes Partner — Partners with smaller causes to amplify their impact through financial assistance and resource sharing.
- smaller causes Partner — Partners with smaller organizations to amplify their impact in cancer research.
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Cancer Biology–Driven Therapy Developmentmethodology: cancer-biology-driven-therapy-developmentBy leveraging deep expertise in cancer biology and genetics, we develop novel therapies for advanced germ cell tumors, because targeting the molecular basis of disease enables more effective and precise interventions.
- Event-Based Fundraising to Sustain Research Philanthropymethodology: event-based_fundraisingBy hosting high-engagement charity events with tiered sponsorships, we generate reliable funding and public visibility for testicular cancer research, because experiential fundraising deepens donor connection and incentivizes sustained participation through branding and engagement benefits.
- Focused Grantmaking to Maximize Research Impactmethodology: focused_grantmakingBy concentrating fundraising proceeds on a single researcher, organization, or cause annually, we achieve greater impact through sustained and targeted support, because focused funding reduces fragmentation and increases the likelihood of measurable progress in specialized cancer research.
- MicroRNA Biomarker Development Across the Care Continuummethodology: multi-application-biomarker-developmentBy developing microRNA-based assays, we enable earlier diagnosis, better treatment monitoring, and improved surgical and surveillance decisions, because molecular biomarkers provide real-time biological insights that enhance clinical decision-making at multiple stages of cancer care.
- Supporting Ingenuity in Cancer Research Through Targeted Fundingmethodology: supporting_ingenuity_in_researchBy funding innovative and unconventional approaches in cancer research, we accelerate breakthroughs in underexplored areas, because high-potential ideas outside mainstream paradigms often lead to transformative advances when given early support.